| David Grand, MD | |
|
593 Eddy St, Providence, RI 02903-4923 | |
| (401) 444-5174 | |
| (401) 453-8220 |
| Full Name | David Grand |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508815978 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rhode Island Medical Imaging | 8022097815 | 108 |
News Archive
World Congress of Cardiology Report - Although elderly AF patients are at much higher risk for stroke, they are undertreated for stroke prophylaxis compared to younger patients.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced the publication of one-year results from two separate prospective multicenter clinical trials as well as the publication of a systematic review of 18 MIS SI joint fusion studies.
Results presented today at The International Liver Congress 2015 show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 mono-infected patients. These results are significant because whilst other combinations have been widely reported on, there have been few data until now regarding the use of SOF/DCV combination in real world situations.
Dr. Jennifer Caudle is an assistant professor of Family Medicine at the Rowan University School of Osteopathic Medicine. Over the years in her busy medical practice, she's heard just about every possible excuse or misconception about the annual flu vaccine.
The value of the biosimilars market segment will account for 2.6% of the biological market by 2016, forecasts a new report from URCH Publishing. However, this forecast assumes biosimilars become permitted under U.S. law by 2012, notes the market strategy report "Biosimilars: A Growing Market - An overview of developments, companies & commercial opportunities".
› Verified 3 days ago
| Entity Name | Rhode Island Medical Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205874930 PECOS PAC ID: 8022097815 Enrollment ID: O20040715000832 |
News Archive
World Congress of Cardiology Report - Although elderly AF patients are at much higher risk for stroke, they are undertreated for stroke prophylaxis compared to younger patients.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced the publication of one-year results from two separate prospective multicenter clinical trials as well as the publication of a systematic review of 18 MIS SI joint fusion studies.
Results presented today at The International Liver Congress 2015 show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 mono-infected patients. These results are significant because whilst other combinations have been widely reported on, there have been few data until now regarding the use of SOF/DCV combination in real world situations.
Dr. Jennifer Caudle is an assistant professor of Family Medicine at the Rowan University School of Osteopathic Medicine. Over the years in her busy medical practice, she's heard just about every possible excuse or misconception about the annual flu vaccine.
The value of the biosimilars market segment will account for 2.6% of the biological market by 2016, forecasts a new report from URCH Publishing. However, this forecast assumes biosimilars become permitted under U.S. law by 2012, notes the market strategy report "Biosimilars: A Growing Market - An overview of developments, companies & commercial opportunities".
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Grand, MD 125 Metro Center Boulevard, Suite 2000, Warwick, RI 02886-1768 Ph: (401) 432-2520 | David Grand, MD 593 Eddy St, Providence, RI 02903-4923 Ph: (401) 444-5174 |
News Archive
World Congress of Cardiology Report - Although elderly AF patients are at much higher risk for stroke, they are undertreated for stroke prophylaxis compared to younger patients.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced the publication of one-year results from two separate prospective multicenter clinical trials as well as the publication of a systematic review of 18 MIS SI joint fusion studies.
Results presented today at The International Liver Congress 2015 show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 mono-infected patients. These results are significant because whilst other combinations have been widely reported on, there have been few data until now regarding the use of SOF/DCV combination in real world situations.
Dr. Jennifer Caudle is an assistant professor of Family Medicine at the Rowan University School of Osteopathic Medicine. Over the years in her busy medical practice, she's heard just about every possible excuse or misconception about the annual flu vaccine.
The value of the biosimilars market segment will account for 2.6% of the biological market by 2016, forecasts a new report from URCH Publishing. However, this forecast assumes biosimilars become permitted under U.S. law by 2012, notes the market strategy report "Biosimilars: A Growing Market - An overview of developments, companies & commercial opportunities".
› Verified 3 days ago
Lars Stangenberg, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2 Dudley St, Suite 470, Providence, RI 02905 Phone: 401-553-8318 Fax: 401-868-2307 | |
Kara Lynne Leonard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Rih Radiation Oncology, Providence, RI 02903 Phone: 401-444-8311 Fax: 401-444-5335 | |
Michael Low Cardenas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 825 N Main St, Providence, RI 02904 Phone: 774-279-0884 | |
Earle O Assanah, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5174 | |
Sarah-kim Shields, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Radiology, Providence, RI 02903 Phone: 401-444-2133 Fax: 401-444-5017 | |
Sean O'neill, MD Radiology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5127 Fax: 401-444-3056 | |
John Scaringi, MD Radiology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-4000 |